The latest research has relieved fears that use of the HIV prevention method would cause an uptick in Hepatitis-C rates.

seen from Canada
seen from China

seen from Australia
seen from China
seen from Canada
seen from Brazil
seen from United States

seen from Canada
seen from China

seen from United States

seen from Canada
seen from Canada
seen from United States
seen from China

seen from United States
seen from China
seen from Bulgaria

seen from Canada
seen from United States

seen from United States
The latest research has relieved fears that use of the HIV prevention method would cause an uptick in Hepatitis-C rates.
Hepatitis- C is a Liver disease. It is caused by infection due to viruses called (HCV). The virus attacks the liver and leads to its inflammation. HCV virus infection remains hidden without the appearance of major symptoms. Symptoms appear... For more details please click on-https://maansisurvivalaidfoundation.com/what-is-hepatitis-c/
रोहतक PGI का दावा- हेपेटाइटिस-C की दवा खाने वाले मरीजों पर नहीं हो रहा कोरोना का असर!
रोहतक PGI का दावा- हेपेटाइटिस-C की दवा खाने वाले मरीजों पर नहीं हो रहा कोरोना का असर!
[ad_1]
हरियाणा में तकरीबन 5000 हेपेटाइटिस-सी के मरीज दवा ले रहे हैं डॉ प्रवीण मल्होत्रा ने बताया कि ब्रिटेन, ब्राजील, ईरान और सऊदी अरब आदि देशों में हेपेटाइटिस-सी (Hepatitis-C) के प्रभावी होने के प्रमाण मिले हैं. इसकी दवा खाने वाले मरीजों पर कोरोना…
View On WordPress
https://www.medicalmarijuana.com/can-medical-marijuana-help-people-hep-c/
First, let’s discuss Hepatitis-C. Hep-C is an autoimmune disease that mainly affects the liver. If left untreated, it can be a fatal disease, slowly eroding the body’s ability to digest food properly. In order to combat Hep-C, you have to take a daily pill regimen to halt the progress of the disease. Unfortunately, these pills can have a large variety of unwanted, and very acute, side effects.
The cure rate following pegylated interferon and ribavirin was only approximately 45%
Between 2002 and the availability in 2013 of the new generation of all-oral direct-acting antiviral treatments for hepatitis C, the mainstay of therapy had been long-acting (“pegylated”) interferon injections along with an oral medication, ribavirin. Both of these medications had bothersome side effects, and a treatment duration of up to 48 weeks was required.
For people with the most common hepatitis C genotype (category of viral infection), genotype 1, the cure rate following pegylated interferon and ribavirin was only approximately 45%.
Hepatitis C is the only curable chronic viral infection of humans
The current generation of combination medications for hepatitis C can lead to a cure
The current generation of all-oral, well tolerated combination medications for hepatitis C can lead to “cure” in approximately 95% of treated patients.
Generally, the duration of treatment is 12 weeks but can be as brief as 8 weeks (and in more advanced cases may be as long as 24 weeks). These drugs are very well tolerated (most people have no side effects); a small proportion experience fatigue, nausea, headache, diarrhea and/or insomnia.
The vast majority of people in the United States with chronic hepatitis C were born between 1945 and 1965 and acquired their infections during adolescence and early adulthood